Cargando…

A real-word study: is normothermic intraoperative intraperitoneal chemotherapy impactful as we expect?

BACKGROUND: Patients with gastric cancer have a poor prognosis. Currently, intraperitoneal chemotherapy has been considered a therapeutic option to improve prognosis due to its appealing theoretical rationales. But there is no consensus on the choice of chemotherapeutic agents used in intraperitonea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Mengyao, Cao, Wei, Chen, Junjie, Xiong, Maoming, Cao, Guodong, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352766/ https://www.ncbi.nlm.nih.gov/pubmed/37469412 http://dx.doi.org/10.3389/fonc.2023.1172782

Ejemplares similares

FHL3 Contributes to EMT and Chemotherapy Resistance Through Up-Regulation of Slug and Activation of TGFβ/Smad-Independent Pathways in Gastric Cancer
por: Cao, Guodong, et al.
Publicado: (2021)

siMTA1-Loaded Exosomes Enhanced Chemotherapeutic Effect of Gemcitabine in Luminal-b Type Breast Cancer by Inhibition of EMT/HIF-α and Autophagy Pathways
por: Li, Pengping, et al.
Publicado: (2020)

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment
por: Jin, Mengyao, et al.
Publicado: (2022)

Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer
por: Li, Pengping, et al.
Publicado: (2020)

Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort
por: Hu, Lei, et al.
Publicado: (2022)

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy
por: Cao, Wei, et al.
Publicado: (2021)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
por: Markman, Maurie
Publicado: (2016)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
por: Mangieri, Christopher W., et al.
Publicado: (2022)

Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis
por: Panuganti, Bharat, et al.
Publicado: (2018)

Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study
por: Ba, Mingchen, et al.
Publicado: (2021)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ramirez, Maria F., et al.
Publicado: (2023)

Achieving Intraperitoneal Disease Control Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Two Cases of Metastatic Breast Cancer
por: Barakat, Philipp, et al.
Publicado: (2023)

Genetic alterations in peritoneal metastatic tumors predicted the outcomes for hyperthermic intraperitoneal chemotherapy
por: Nguyen, Quynh-Anh, et al.
Publicado: (2023)

Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rubio-López, Jesús David, et al.
Publicado: (2023)

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses
por: Souadka, Amine, et al.
Publicado: (2022)

Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy
por: Kang, Hui-xia, et al.
Publicado: (2023)

Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial–mesenchymal transition in gastric cancer
por: He, Xiaobo, et al.
Publicado: (2022)

Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Blanco, Ana, et al.
Publicado: (2013)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects
por: Solaß, Wiebke, et al.
Publicado: (2013)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015)

Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
por: Tentes, Antonios-Apostolos K., et al.
Publicado: (2012)

Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Yoon, Ji-Young, et al.
Publicado: (2014)

Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer
por: Shang, An, et al.
Publicado: (2021)

Intraoperative parameters and postoperative follow-up of foam-based intraperitoneal chemotherapy (FBIC)
por: Khosrawipour, Carolina, et al.
Publicado: (2023)

Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity
por: Lang, Noemie, et al.
Publicado: (2023)

A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients
por: Ding, Jianfeng, et al.
Publicado: (2021)

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
por: Bai, Yun, et al.
Publicado: (2023)

Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors
por: Wang, Zhi-Jie, et al.
Publicado: (2019)

Peritoneal Metastasis of Cholangiocarcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy at the Instituto Nacional de Cancerología, Colombia
por: Hernandez, Dary L, et al.
Publicado: (2020)

Ascites and Serial Plasma Circulating Tumor DNA for Predicting the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis
por: Pu, Xiaolin, et al.
Publicado: (2022)

Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study
por: Zhong, Yuxin, et al.
Publicado: (2023)

Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles
por: Zhang, Jing, et al.
Publicado: (2023)

Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis
por: Feng, Xudong, et al.
Publicado: (2020)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
por: Canda, Aras Emre, et al.
Publicado: (2018)

Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003–2008: The Effect of the NCI Clinical Recommendation
por: Bowles, Erin J. Aiello, et al.
Publicado: (2014)

Racial Disparities in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Aggressive Surgical Treatment Overcome Cancer Health Inequities?
por: Freudenberger, Devon C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6shphq5a9ragapeiahc69odkkp